Age-dependent membrane release and degradation of full-length glycosylphosphatidylinositol-anchored proteins in rats.


Journal

Mechanisms of ageing and development
ISSN: 1872-6216
Titre abrégé: Mech Ageing Dev
Pays: Ireland
ID NLM: 0347227

Informations de publication

Date de publication:
09 2020
Historique:
received: 18 03 2020
revised: 18 06 2020
accepted: 29 06 2020
pubmed: 7 7 2020
medline: 14 9 2021
entrez: 7 7 2020
Statut: ppublish

Résumé

Glycosylphosphatidylinositol (GPI)-anchored proteins (GPI-APs) are associated with the surface of eucaryotic cells only through a covalently coupled carboxy-terminal GPI glycolipid structure which is anchored at the outer leaflet of plasma membranes. This mode of membrane association may be responsible for the recent observations that full-length GPI-APs harbouring the complete GPI anchor are (i) released from isolated rat adipocytes in vitro and (ii) expressed in rat and human serum. The upregulation of the adipocyte release in response to increased cell size and blood glucose/insulin levels of the donor rats and downregulation of the expression in serum of insulin resistant and diabetic rats have been reconciled with enhanced degradation of the full-length GPI-APs released into micelle-like complexes together with (lyso) phospholipids and cholesterol by serum GPI-specific phospholipase D (GPI-PLD). Here by using a sensitive and reliable sensing method for full-length GPI-APs, which relies on surface acoustic waves propagating over microfluidic chips, the upregulation of (i) the release of the full-length GPI-APs CD73, alkaline phosphatase and CD55 from isolated adipocyte plasma membranes monitored in a "lab-on-the-chip" configuration, (ii) their release from isolated rat adipocytes into the incubation medium and (iii) the lipolytic cleavage of their GPI anchors in serum was demonstrated to increase with age (3-16 weeks) and body weight (87-477 g) of (healthy) donor rats. In contrast, the amount of full-length GPI-APs in rat serum, as determined by chip-based sensing, turned out to decline with age/body weight. These correlations suggest that age-/weight-induced alterations (in certain biophysical/biochemical characteristics) of plasma membranes are responsible for the release of full-length GPI-APs which becomes counteracted by elevated GPI-PLD activity in serum. Thus, sensitive and specific measurement of these GPI-AP-relevant parameters may be useful for monitoring of age-related cell surface changes, in general, and diseases, in particular.

Identifiants

pubmed: 32628941
pii: S0047-6374(20)30103-2
doi: 10.1016/j.mad.2020.111307
pii:
doi:

Substances chimiques

GPI-Linked Proteins 0
Glycosylphosphatidylinositols 0
Cholesterol 97C5T2UQ7J
Phospholipase D EC 3.1.4.4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

111307

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Auteurs

Günter A Müller (GA)

Institute for Diabetes and Obesity, Helmholtz Diabetes Center (HDC) at Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Oberschleissheim, Germany; German Center for Diabetes Research (DZD), Oberschleissheim, Germany; Department Biology I, Genetics, Ludwig-Maximilians-Universität München, Planegg, Martinsried, Germany. Electronic address: guenter.mueller@helmholtz-muenchen.de.

Siegfried Ussar (S)

Institute for Diabetes and Obesity, Helmholtz Diabetes Center (HDC) at Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Oberschleissheim, Germany; German Center for Diabetes Research (DZD), Oberschleissheim, Germany; Division of Metabolic Diseases, Department of Medicine, Technische Universität München, München, Germany.

Matthias H Tschöp (MH)

German Center for Diabetes Research (DZD), Oberschleissheim, Germany; Division of Metabolic Diseases, Department of Medicine, Technische Universität München, München, Germany; Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Oberschleissheim, Germany.

Timo D Müller (TD)

Institute for Diabetes and Obesity, Helmholtz Diabetes Center (HDC) at Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Oberschleissheim, Germany; German Center for Diabetes Research (DZD), Oberschleissheim, Germany; Department of Pharmacology and Experimental Therapy, Institute of Experimental and Clinical Pharmacology and Toxicology, Eberhard Karls University Hospitals and Clinics, Tübingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH